|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | 0.00% |
|
+8.33% | -13.33% |
| Feb. 28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 09 | TrivarX Signs Collaboration with Northern Michigan University on Sleep Research | MT |
TrivarX Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 0.022074 million compared to AUD 0.040038 million a year ago. Net loss was AUD 3.12 million compared to AUD 12.72 million a year ago.
Basic loss per share from continuing operations was AUD 0.018 compared to AUD 0.124 a year ago. Diluted loss per share from continuing operations was AUD 0.018 compared to AUD 0.124 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.33% | 5.74M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
TRIVARX LIMITED 
